Company · CIK 0001169245
PhaseBio Pharmaceuticals Inc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-24-201295 · 2.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-178615 · 6.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-140615 · 3.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-065935 · 6.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001169245-23-000056 · 9.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001169245-23-000052 · 158.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001169245-23-000050 · 4.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001169245-23-000047 · 8.9 MBSEC(opens sec.gov)
- 8-KCurrent report0001169245-23-000039 · 4.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001169245-23-000035 · 4.7 MBSEC(opens sec.gov)
Insiders
- Arnold Susan ElizabethSVP, Technical Operations
- ASTRAZENECA PLC10% Owner
- Ballance David JamesVP, Research and Sci. Affairs
- BARRETT M JAMES10% Owner
- BARRIS PETER J10% Owner
- BASKETT FOREST10% Owner
- Birchall JonathanChief Commercial Officer
- Burkhardt GlenSVP of Human Resources
- Catalysta Ventures, LLC10% Owner
- Hanson KristopherSVP and General Counsel
Tickers
No tickers on record.
Addresses
business
1 GREAT VALLEY PARKWAY SUITE 30
MALVERN, PA, 19355
mailing
1 GREAT VALLEY PARKWAY SUITE 30
MALVERN, PA, 19355
Former names
- Phase Biosciences Inc2008-04-23
- DT BIOSCIENCES INC2004-05-11
Same industry